Tiger Liquidity Services Warns of Risks of Excess Assets in Biopharma Sector
Tiger Liquidity Services Warns of Risks of Excess Assets in Biopharma Sector
Analysis by Tiger Liquidity Services Biopharma Partnership underscores the strategic value to hedge funds, private equity firms, asset-based lenders, and bankruptcy professionals of leveraging asset-valuation and disposition in the biopharma/pharmaceutical space
Tiger Liquidity Services Biopharma Partnership has issued a primer on how investors and lenders can bolster the position of biopharmaceutical firms by leveraging asset […]